Stock MURA MURAL ONCOLOGY PLC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Mural Oncology plc

Equities

MURA

IE000LK2BOB4

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-07 EDT 		5-day change 1st Jan Change
3.35 USD +0.30% Intraday chart for Mural Oncology plc -0.30% -43.41%
04-04 Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target MT
01-08 Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
GL
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
GL
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
AQ
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
GL
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GL
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
GL
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
GL
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
AQ
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
GL
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
AQ
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
GL
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MURA Stock
  4. News Mural Oncology plc
  5. Press Releases